If approved in Japan, the drug would become the country's third antiviral cleared for coronavirus patients following those developed by Pfizer and Merck

The company may recommend against pregnant women using its antiviral pill after animal testing found foetal abnormalities

China's medical products regulator has given conditional approval for Pfizer's Covid-19 treatment Paxlovid, making it the first pill approved in the country to treat the disease.